Canaloplasty for open angle glaucoma: a three years critical evaluation and comparison with viscocanalostomy
Tóm tắt
OBJECTIVE: Patients undergoing primary Canaloplasty for open angle glaucoma, under the care of the two authors, were entered into a common data base. The two authors also pooled their results at three years, from a prospective audit of patients undergoing Viscocanalostomy, from the same sites, in order to provide a comparison of the successes and complications of the two procedures. PATIENTS AND METHODS: Surgery was carried at: Warrington Hospital, Warrington, UK; Spire Cheshire Hospital, Stretton, UK; Augencentrum Porz, Cologne, Germany and University Eye Hospital Padua, Italy, between May 1997 and May 2008. Ninety seven eyes of 75 patients underwent Canaloplasty with a mean age of 67 years (range 41 to 85 years) and a mean follow up of 19 months (range 6 months to 3 years). One hundred and twenty eyes of 92 patients had undergone Viscocanalostomy with a mean age of 68 years (range 26 to 92 years) and a mean follow up of 22 months (range: 3 months to 3 years). RESULTS: There were no statistically significant differences in the mean pre-operative IOP and number of medications between groups. Both Canaloplasty and Viscocanalostomy groups showed a statistically significant reduction in IOP (t = 19.25. p < 0.05 and 15.54. p < 0.05 respectively) and number of medications (t = 21.18 p < 0.05 and 23.04 p < 0.05 respectively) from pre-operative levels. There was a statistically significant difference in favour of the Canaloplasty group in post-operative reduction of both IOP and number of medications compared with the Viscocanalostomy group (Mann-Whitney U 3940.5 and 4109.5 p = < .001 respectively). Of the 97 eyes that underwent Canaloplasty, using the criteria of success as ≤ 21 mm Hg, a success rate of 97% with medication and 92% with no medication was achieved. When success is defined at ≤ 17 mm Hg, the success rate was 87% with medication and 83% with no medication. For the 120 eyes undergoing Viscocanalostomy, using the criteria of success as ≤ 21 mm Hg, a success rate of 96% on medication and 55% with no medication was achieved. However, when success is defined at ≤ 17 mm Hg the success rate drops to 68% on medication and 42% with no medication. There was a statistically significant difference between groups in favour of the Canaloplasty group in the number of patients achieving a post-operative IOP of 17mm Hg or less (t = 2.55 p = .001). CONCLUSIONS: The results reported here show that both Viscocanalostomy and Canaloplasty are safe and effective surgical procedures for the management of Primary Open Angle Glaucoma with fewer complications than the current literature states for trabeculectomy. Moreover, when the results of these two groups of similar patients are compared, Canaloplasty produced significantly better results than Viscocanalostomy.
Tài liệu tham khảo
Stegmann R, Pienaar A, Miller D (1991) Viscocanalostomy for open-angle glaucoma in black African patients. J Cataract Refract Surg 25: 316–322
The Advanced Glaucoma Intervention Study (AGIS) (2000) 7 Am J Ophthalmol 130: 429–440
Wishart PK (2008) Trabeculectomy is not the best surgical option for glaucoma. Eye 22: 603–606
Franks W (2005) Trypan blue staining of antiproliferative agents for trabeculectomy surgery and bleb needling. Br J Ophthalmol 89: 1394–1395
Liebmann JM, Ritch R (2000) Bleb related ocular infection: a feature of the HELP Syndrome. Hypotony, endophthalmitis, leak, pain. Br J Ophthalmol 84: 1338–1339
Smith SD, Katz J, Quigley HA (1996) Analysis of progressive change in automated visual fields in glaucoma. Invest Ophthalmol Vis Sci 37: 1419–1428
Mietz H, Krieglstein GK (2001) Suramin to enhance glaucoma filtering procedures: a clinic comparison with mitomycin. Ophthalmic Surg Laser 32: 358–369
Megevand GS, Salmon JF, Scholtz RP, Murray AD (1995) The effect of reducing the exposure time of mitomycin C in glaucoma filtering surgery. Ophthalmology 102: 84–90
Greenfield DS, Suner IJ, Miller MP Kangas TA, Palmberg PF, Flynn Jr HW (1996) Endophthalmitis after filtering surgery with mitomycin. Arch Ophthalmol 114: 943–949
Akarsu C, Onol M, Hasanreisoglu B (2003) Effects of thick Tenon's capsule on primary trabeculectomy with mitomycin-C. Acta Ophthalmol Scand 81: 237–241
Beck AD, Wilson WR, Lynch MG, Lynn MJ, Noe R (1998) Trabeculectomy with adjunctive mitomycin C in pediatric glaucoma. Am J Ophthalmol 126: 648–657
Membrey WL, Bunce C, Poinoosawmy DP, Fitzke FW, Hitchings RA (2001) Glaucoma surgery with or without adjunctive antiproliferatives in normal tension glaucoma: 2 visual field progression. Br J Ophthalmol 85: 696–701
Wells AP, Cordeiro MF, Bunce C, Khaw PT (2003) Cystic bleb formation and related complications in limbus- vs fornix-based conjunctival flaps in pediatric and young adult trabeculectomy with mitomycin C. Ophthalmology 110: 2192–2197
Belyea DA, Dan JA, Lieberman MF, Stamper RL (1997) Midterm follow-up results of combined phacoemulsification, lens implantation and mitomycin-C trabeculectomy procedure. J Glaucoma 6: 90–98
Alwitry A, Patel V, King AW (2005) Fornix vs limbal-based trabeculectomy with mitomycin C. Eye 19: 631–636
Stalmans I, Gillis A, Lafaut AS, Zeyen T (2006) Safe trabeculectomy technique: long term outcome. Br J Ophthalmol 90: 44–47
Scott IU, Greenfield DS, Schiffman J, Nicholela MT, Rueda JC, Tsai JC, et al (1998) Outomes of primary trabeculectomy with the use of adjunctive mitomycin. Arch Ophthalmol 116: 286–291
Bindlish R, Condon GP, Schlosser JD, D'Antonio J, Lauer KB, Lehrer R (2002) Efficiency and safety of mitomycin-C in primary trabeculectomy: five year follow up. Ophthalmology 109: 1336–1341
Lewis R, von Wolff K, Tetz M, Körber N, Kearney J, Shingleton B, Samuelson T (2007) Canaloplasty: circumferential viscodilation and tensioning of Schlemm's canal using a flexible microcatheter for the treatment of open-angle glaucoma in adults Interim clinical study analysis. J Cataract Refract Surg 33: 1217–1226
Edmunds B, Thompson JR, Salmon JF, Wormald RP (2002) The National Survey of Trabeculectomy. III. Early and late complications. Eye 16: 297–303